Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Natco Pharma Limited
NATCOPHARMNATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India. Address: Natco House, Hyderabad, India, 500034
Analytics
Precio Objetivo de WallStreet
113 397.63 INRRelación P/E
12.6742Rentabilidad por dividendo
0.4 %Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave NATCOPHARM
Análisis de dividendos NATCOPHARM
Aumento del dividendo durante 5 años
12 %Crecimiento continuo
2 añoRatio de pago medio en 5 años
32 %Tendencia del payout NATCOPHARM
Valoración de la acción NATCOPHARM
Finanzas NATCOPHARM
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |